BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32286869)

  • 1. Prediction of Response to Tumor Necrosis Value-α Blocker Is Suggested by
    Kim K; Son SM; Goh TS; Pak K; Kim IJ; Lee JS; Kim SJ
    AJR Am J Roentgenol; 2020 Jun; 214(6):1352-1358. PubMed ID: 32286869
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of semi-quantitative index from F-18-fluoride PET/CT for treatment response in patients with ankylosing spondylitis.
    Lee SJ; Kim JY; Choi YY; Lee S; Joo YB; Kim TH
    Eur J Radiol; 2020 Aug; 129():109048. PubMed ID: 32446125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.
    Bruijnen STG; Verweij NJF; van Duivenvoorde LM; Bravenboer N; Baeten DLP; van Denderen CJ; van der Horst-Bruinsma IE; Voskuyl AE; Custers M; van de Ven PM; Bot JCJ; Boden BJH; Lammertsma AA; Hoekstra OSH; Raijmakers PGHM; van der Laken CJ
    Rheumatology (Oxford); 2018 Apr; 57(4):631-638. PubMed ID: 29329443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.
    Idolazzi L; Salgarello M; Gatti D; Viapiana O; Vantaggiato E; Fassio A; Adami S; Rossini M
    Ann Nucl Med; 2016 Jul; 30(6):430-4. PubMed ID: 27137206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the diagnostic performance of
    Son SM; Kim K; Pak K; Kim SJ; Goh TS; Lee JS
    Spine J; 2020 Sep; 20(9):1471-1479. PubMed ID: 32198119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of Radium-223 Dichloride and Early [
    Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
    Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of quantitative analysis in
    Lapa P; Marques M; Costa G; Lima JP
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
    Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 fluoride uptake in primary breast cancer.
    Sarikaya I; Sharma P; Sarikaya A
    Ann Nucl Med; 2018 Dec; 32(10):678-686. PubMed ID: 30178199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.
    Donners R; Tunariu N; Tovey H; Hall E; Chua S; Cook G; Du Y; Blackledge MD; Parker CC; Koh DM
    Eur Radiol; 2024 Feb; 34(2):1146-1154. PubMed ID: 37615760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of
    Raynal M; Bouderraoui F; Ouichka R; Melchior J; Morel O; Blum A; Chary-Valckenaere I; Ngueyon Sime W; Roch V; Maksymowych W; Lambert RG; Olivier P; Loeuille D
    Arthritis Res Ther; 2019 May; 21(1):119. PubMed ID: 31088514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
    Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
    J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of
    Yellanki DP; Kothekar E; Al-Zaghal A; Cheng N; Werner TJ; Høilund-Carlsen PF; Alavi A
    Hell J Nucl Med; 2018; 21(3):181-185. PubMed ID: 30411728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Coronary
    Kwiecinski J; Adamson PD; Lassen ML; Doris MK; Moss AJ; Cadet S; Jansen MA; Dey D; Lee SE; Yun M; Chang HJ; Dweck MR; Newby DE; Berman DS; Slomka PJ
    Circ Cardiovasc Imaging; 2018 Dec; 11(12):e008325. PubMed ID: 30558496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
    J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
    Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
    Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study.
    Inman RD; Baraliakos X; Hermann KA; Braun J; Deodhar A; van der Heijde D; Xu S; Hsu B
    Arthritis Res Ther; 2016 Dec; 18(1):304. PubMed ID: 28031053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat Mass Lowers the Response to Tumor Necrosis Factor-α Blockers in Patients with Ankylosing Spondylitis.
    Ibáñez Vodnizza SE; Nurmohamed MT; Visman IM; van Denderen JC; Lems WF; Jaime F; van der Horst-Bruinsma IE
    J Rheumatol; 2017 Sep; 44(9):1355-1361. PubMed ID: 28711878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.